Biondvax pharmaceuticals SCNI.US Value Analysis
US StockHealth Care
(No presentation for SCNI)
SCNI Value Score
3
24
15
Limited Growth
- AI analysis rates SCNI with a lower value score of 2.
- It is mainly due to unstable operating cash flow, along with potential value may be lower.
- Over the past 3 months, SCNI has maintained a consecutive value rating of 2.0, close to the rating of 2.2 over the past 3 years, indicating low growth opportunities for enterprise value.
- Compared to all stocks in the Health Care sector, SCNI has a medium value rating.
SCNI Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
No related data records
Update to 2024/12/16 (Weekly Update)
SCNI Financial Forecast
Unit : USD
Update to 2025/5/9 (Quarterly Update)
SCNI Earnings Table
No related data records
SCNI Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
SCNI Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of SCNI from 2015/05 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from May, 2015 to May, 2025. (Total Trades: 0)
| SCNI | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 44% | 54% |
| Avg Return | - | 63.5% | 72.8% |
| Avg Profit | - | 198.7% | 166% |
| Avg Loss | - | -44.7% | -34.6% |
| Avg Risk-Reward Ratio | - | 444.3% | 479.7% |
Update to 2025/5/9 (Daily Update)